Accellix Raises $10 Million From BroadOak Capital Partners

SAN JOSE, Calif. & BETHESDA, Md.--(BUSINESS WIRE)-- #biotechnology--Accellix Inc., which provides quick and accurate flow cytometry results in a compact and easy-to-use platform designed for use by cell therapy companies on the manufacturing floor and at the point-of-need, today announced that it has raised $10 million from BroadOak Capital Partners....

Click to view original post